Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07341139 · ClinicalTrials.gov registry record
Blood Storage Related Mortality and Adverse Effects in Trauma Patients
A clinical trial of Transfusion Adverse Reaction and Major Trauma, sponsored by Kocaeli City Hospital.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT07341139 is a study of Transfusion Adverse Reaction and Major Trauma that is actively recruiting participants, run by Kocaeli City Hospital. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07341139, a study of Transfusion Adverse Reaction and Major Trauma, is actively recruiting participants, sponsored by Kocaeli City Hospital.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this retrospective study is to examine the following factors related to blood storage time in severely injured trauma patients who received large blood transfusions: 1. The effect of blood storage time on the patient's 28-day mortality rate. 2. The relationship between storage time and other health problems that the patient may develop (such as heart disease, vascular occlusion, respiratory failure, infection, and organ failure). For this purpose, patients aged 18-75 who were admitted directly from the scene of injury and received large transfusions at Jacksonville Shands Hospital between January 1, 2023, and October 1, 2025, will be included. Data will be obtained from hospital information systems and anesthesia records
Conditions Studied
Study Locations (1)
Florida
- UF Health Jacksonville (Shands Hospital) - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-01-17 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07341139
The ClinicalTrials.gov registry entry for NCT07341139 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kocaeli City Hospital, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Transfusion Adverse Reaction appearing as the primary indexed condition, and to 0 interventions.
NCT07341139 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07341139 about?
NCT07341139 is a clinical study titled "Blood Storage Related Mortality and Adverse Effects in Trauma Patients". The purpose of this retrospective study is to examine the following factors related to blood storage time in severely injured trauma patients who received large blood transfusions: 1. The effect of blood storage time on the patient's 28-day mortality rate. 2. The relationship between storage time a...
What is the current status of trial NCT07341139?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2026-01-17. Estimated completion is 2026-06-01.
What conditions does trial NCT07341139 study?
This clinical trial studies the following conditions: Transfusion Adverse Reaction, Major Trauma, Blood Product Transfusion for All Conditions.
Who is sponsoring clinical trial NCT07341139?
This trial is sponsored by Kocaeli City Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07341139 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.